Buy Tofacitinib Citrate Manufacturer & Supplier

Enterprise-Grade API Manufacturing, Chiral Engineering & Global cGMP Supply Chain Solutions

Featured Pharmaceutical Active Ingredients & Intermediates

Explore our high-purity API catalog produced under stringent international cGMP and ISO quality standards.

Melanotan II

High-Quality Melanotan II Manufacturer, Company

View Details
Acetyl Tributyl Citrate

Buy Acetyl Tributyl Citrate Used as Plasticizer and Stabilizer Manufacturers, Factories

View Details
Sebacic Acid Di-N-Octyl Ester

OEM SEBACIC ACID DI-N-OCTYL ESTER 2432-87-3 Suppliers, Exporters

View Details
Dibutyl Phthalate

Wholesale Dibutyl Phthalate Used as Pasticizer for Nitrocellulose Factory, Exporter

View Details
Daptomycin

High-Quality Daptomycin 103060-53-3 for Infectious Diseases Suppliers, Companies

View Details
GHRP-2 5mg

Buy GHRP-2 5mg Manufacturer, Product

View Details
Human Growth Hormone

Wholesale Human Growth Hormone for Children and Body Building Companies, Product

View Details
Semaglutide

Buy Semaglutide for Type 2 Diabetes Manufacturer, Factory

View Details
250,000 m²
cGMP Production Base
> 99.5%
API Assay Purity
10+
Global Representative Hubs
100%
ICH Regulatory Compliance

Tofacitinib Citrate (CAS 540737-29-9) Technical Dossier & Synthesis Dynamics

A comprehensive examination of chemical architecture, targeted Janus Kinase inhibition, and stereo-specific purity control.

Molecular Mechanism & Chiral Integrity

Tofacitinib Citrate (Chemical Formula: C16H20N6O · C6H8O7, MW: 504.49 g/mol) is a potent, selective small-molecule oral inhibitor of the Janus Kinase (JAK) family. It specifically targets JAK1 and JAK3 enzymes, effectively blocking the signaling trans-phosphorylation of Signal Transducer and Activator of Transcription (STAT) proteins. This targeted pathway downstream suppresses critical pro-inflammatory cytokines including IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21.

From a synthetic chemistry perspective, achieving absolute chiral resolution at the 3R,4R pyrrolo[2,3-d]pyrimidine backbone is paramount. Gentolex utilizes proprietary asymmetric enzymatic reduction and diastereomeric salt crystallization techniques to guarantee an enantiomeric excess (e.e.) exceeding 99.8%, effectively eliminating unwanted stereoisomers that compromise therapeutic safety profiles.

Polymorphism & Particle Size Distribution (PSD)

The bioavailability and dissolution profile of Tofacitinib Citrate oral solid formulations (FDF) depend directly on the control of crystal polymorphism. Our dedicated API crystallization suites produce pure Polymorphic Form I consistently, validated through Powder X-Ray Diffraction (PXRD) and Differential Scanning Calorimetry (DSC).

To cater to diverse drug release systems—including immediate-release, modified-release, and topical dermatological formulations—we offer customized micronization services using fluid energy jet milling. Particle size distributions can be tailored to exact specifications (e.g., D90 < 10 μm, D50 < 3 μm) with controlled specific surface area (SSA) parameters to optimize wet-granulation and direct-compression tableting processes.

Tofacitinib Citrate API Quality Specifications (cGMP Standard)

Comprehensive analytical benchmarks verified via validated HPLC, GC-MS, LC-MS/MS, and ICP-MS testing protocols.

Parameter Analytical Specification Testing Methodology
Chemical Name 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile citrate IUPAC / InChI Standard
CAS Registry Number 540737-29-9 CAS Official Index
Appearance White to off-white crystalline powder Visual inspection
Identification (IR, HPLC, PXRD) Conforms to Reference Standard / Form I Characteristic Peaks FTIR / PXRD Comparison
Assay (HPLC, Anhydrous basis) 99.0% – 101.0% w/w USP / Ph. Eur. HPLC Method
Enantiomeric Purity (Chiral HPLC) ≥ 99.8% (3R,4R Isomer); Single Enantiomer ≤ 0.10% Chiral Stationary Phase HPLC
Related Substances (Impurities) Individual Impurity ≤ 0.10%; Total Impurities ≤ 0.50% RP-HPLC / LC-MS
Heavy Metals / Elemental Impurities Meets ICH Q3D limits (Pb ≤ 5ppm, As ≤ 1.5ppm, Cd ≤ 0.5ppm, Hg ≤ 1.5ppm) ICP-MS Method
Residual Solvents Methanol < 3000ppm, Isopropanol < 5000ppm, Ethyl Acetate < 5000ppm Headspace GC-FID
Water Content (Karl Fischer) ≤ 0.5% w/w Karl Fischer Coulometric Titration
Bacterial Endotoxins < 0.35 EU/mg (For Parenteral/Specialized Formulations) LAL Kinetic Chromogenic Method

Global Commercial Demand & Enterprise Procurement Strategy

Mitigating supply chain risks and empowering global pharmaceutical brands with reliable multi-ton active ingredient sourcing.

Expanding Therapeutic Indications

Originally approved for moderate to severe Rheumatoid Arthritis (RA), Tofacitinib Citrate has expanded into vast global therapeutic markets including Psoriatic Arthritis, Ulcerative Colitis (UC), Juvenile Idiopathic Arthritis (JIA), and Ankylosing Spondylitis. Furthermore, ongoing clinical investigations into topical alopecia areata and vitiligo solutions are exponentially driving demand for premium micronized raw material APIs.

Supply Chain Security & Risk Mitigation

Global pharmaceutical procurement officers face stringent regulatory hurdles, intermediate shortages, and geopolitical supply volatility. Gentolex resolves these bottlenecks through backwards-integrated key starting material (KSM) synthesis, multi-site backup batch manufacturing, and strategic regional warehousing—ensuring zero supply chain disruption for commercial partners.

Custom Packaging & Bulk Logistics

To preserve chemical stability and eliminate moisture absorption, Tofacitinib Citrate API is packaged in double food/pharma-grade PE bags placed inside heat-sealed aluminum foil barrier bags, packed within heavy-duty fiber drums (5kg, 10kg, 25kg standard units). Temperature-controlled, cold-chain, and expedite customs clearance arrangements are fully supported worldwide.

Technical Roadmap: Advanced Synthetic Engineering & Green Chemistry

Sustainable, scalable, and high-yield chemical synthesis processes engineered for maximum purity and minimal environmental footprint.

Catalytic Hydrogenation & Chiral Resolution Roadmap

Our enhanced commercial synthetic route utilizes 4-chloro-7H-pyrrolo[2,3-d]pyrimidine and (3R,4R)-1-benzyl-N,4-dimethylpiperidin-3-amine as core structural precursors. Key engineering improvements include:

  • High-Efficiency Heterogeneous Catalysis: Replacement of traditional stoichiometric reagents with recyclable Palladium on Carbon (Pd/C) and continuous flow hydrogenation micro-reactors, achieving >98% conversion rates.
  • Environmentally Sustainable Solvents: Transitioning away from hazardous chlorinated solvents toward green solvent systems (such as 2-Methyltetrahydrofuran and ethanol-water mixtures), drastically lowering VOC emissions.
  • In-Line Process Analytical Technology (PAT): Utilizing real-time Process FTIR and NIR spectroscopy to monitor reaction progress, crystal nucleation, and end-point detection.

Impurity Profiling & Genotoxic Impurity (GTI) Control

In accordance with ICH M7 guidelines, controlling mutagenic and genotoxic impurities is a core requirement for regulatory approvals. Gentolex's dedicated Analytical R&D team has established quantitative LC-MS/MS assays capable of detecting potential alkylating agents and nitrosamine precursors down to sub-ppm thresholds.

Every single batch of Tofacitinib Citrate API undergoes rigorous testing to guarantee that trace impurities—such as 4-chloropyrrolo[2,3-d]pyrimidine residues and nitrosamine derivatives—remain far below the acceptable toxicological threshold (TTC < 1.5 μg/day).

About Gentolex Group: Global Infrastructure & Licensing Services

Connecting global healthcare sectors with certified chemical engineering excellence, robust production capacities, and custom licensing.

World-Class Manufacturing Base & Global Hubs

Gentolex's goal is to create opportunities connecting the world with better services and guaranteed products. Up to date, Gentolex Group has been serving customers from more than 10 countries, specially, representatives are established in Mexico and South Africa.

Our main manufacturing capabilities feature an overall factory construction area of 250,000 square meters under strict international cGMP standards to offer flexible, scalable, and cost-effective solutions. We maintain state-of-the-art cleanrooms (Class 100,000 and Class 10,000), automated synthetic reactors ranging from 100L pilot scale to 5000L commercial scale, and specialized peptide synthesis facilities.

Core Turnkey Chemical & Pharmaceutical Solutions

For clients seeking comprehensive commercial partnership, our core competencies include:

  • Peptide APIs & Custom Peptides: Solid-phase peptide synthesis (SPPS) and liquid-phase synthesis for therapeutic and research grade peptides.
  • FDF License Out: Finished Dosage Form licensing, technical transfer packages, and bioequivalence (BE) study support.
  • Technical Support & Consultation: Analytical method validation (AMV), process optimization, and regulatory audit readiness.
  • Product Line & Lab Setup: Customized laboratory architecture design, analytical instrument sourcing, and cGMP compliance setup.
  • Sourcing & Supply Chain Solutions: End-to-end customized procurement services leveraging our comprehensive international supply network.

Regulatory Compliance & Global Localization Support

Full spectrum CTD/eCTD dossier documentation ensuring rapid regulatory registration across international jurisdictions.

US FDA DMF

Active Drug Master File (DMF) registered with the US FDA, facilitating seamless reference for ANDA and NDA filings.

EU CEP / COS

Compliant with European Pharmacopoeia (Ph. Eur.) standards, supported by Certificate of Suitability (CEP) documentation.

cGMP & WHO Standards

Inspected and certified by leading national health authorities adhering to ICH Q7 cGMP guidelines for active pharmaceutical ingredients.

Regional LatAm & Africa Hubs

Direct local regulatory submission assistance and rapid regional fulfillment through our established hubs in Mexico and South Africa.

Frequently Asked Questions (Commercial & Technical Q&A)

Expert answers addressing API procurement, technical specifications, quality assurance, and global logistics.

1. What is the assay purity level of Gentolex's Tofacitinib Citrate API?
Our Tofacitinib Citrate API consistently achieves an assay purity of 99.0% to 101.0% on an anhydrous basis (HPLC), with total related substances kept strictly below 0.50% and any individual impurity below 0.10%. Each batch comes with a comprehensive Certificate of Analysis (CoA).
2. Can Gentolex provide specific particle size distributions (PSD) for tableting or topical formulations?
Yes. We offer fully customized micronization services. Whether your formulation requires standard unmicronized crystalline powder or ultra-fine micronized grades (such as D90 < 10 μm), we can tailor the physical properties to match your exact wet granulation, dry granulation, or direct compression requirements.
3. Are DMF and regulatory documentation packages available for registration?
Absolutely. We supply complete Drug Master Files (DMF in eCTD format), stability data according to ICH Q1A(R2) protocols (accelerated, intermediate, and long-term), elemental impurity risk assessments (ICH Q3D), residual solvent reports (ICH Q3C), and validation packages to support your health authority submissions worldwide.
4. What are the recommended storage conditions and shelf-life of Tofacitinib Citrate API?
Tofacitinib Citrate API should be stored in tightly closed containers protected from light and moisture, preferably at controlled room temperature (15°C to 30°C) or cool conditions (2°C to 8°C depending on stability requirements). Under recommended conditions, the retest period is 24 to 36 months.
5. How does Gentolex assist clients in overcoming multi-contact supply chain complexities?
For clients who prefer to avoid dealing with multiple vendors, Gentolex provides customized procurement services, handling KSM sourcing, API production, quality control, analytical testing, regulatory filing, and end-to-end international logistics under a single accountable contract.
6. What Minimum Order Quantities (MOQ) do you support for R&D versus commercial scale?
We support the complete drug development lifecycle. We provide R&D sample quantities (100g to 1kg) for laboratory formulation development and pilot trials, up to commercial bulk orders measured in metric tons.

Latest News & Scientific Research Insights

Stay updated with technological breakthroughs, technical papers, and manufacturing innovations from Gentolex Group.

Selank Acetate API

High-Purity Selank Acetate API | Peptide Manufacturing and Global Supply

Selank Acetate API is a synthetic heptapeptide active pharmaceutical ingredient composed of the amino acid sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro. Learn about our large-scale synthesis capabilities...

View Details
Thymosin Beta-4 API

Thymosin Beta-4 API Manufacturer & Supplier | High Purity Tβ4 Peptide API

As a professional Thymosin Beta-4 API manufacturer and supplier, we provide high-quality Thymosin Beta-4 peptide API solutions for biotechnology companies and research institutions worldwide...

View Details
BPC-157 API

BPC-157 API Manufacturer | High Purity Peptide Raw Material

BPC-157 API is a synthetic pentadecapeptide gaining substantial attention in tissue repair, gastrointestinal protection, and anti-inflammatory pathways. Explore our synthetic analytical control...

View Details
Semax API

Semax API Manufacturer & Supplier | High Purity Research Grade Peptide

With continuous developments in neuroscience and peptide technology, Semax API stands as an important neuroactive peptide derived from ACTH fragments. Read our technical analysis...

View Details
SS-31 API

SS-31 (Elamipretide) API Manufacturer & Supplier

SS-31 API (Elamipretide) is a targeted mitochondria-stabilizing tetrapeptide designed to support cellular bioenergetics. Learn more about our specialized peptide production lines...

View Details

Additional High-Purity APIs, Peptides & Specialty Intermediates

Discover our expanded portfolio of custom synthesized molecules, FDF offerings, and fine chemicals.

Atosiban Acetate

Buy Atosiban Acetate Used for Anti Premature Birth Factory, Factories

View Details
GHRP-2 10mg

Wholesale GHRP-2 10mg Lyophilized powder Manufacturers, Exporter

View Details
Terlipressin Acetate

OEM Terlipressin Acetate for Esophageal Variceal Bleeding Supplier, Exporter

View Details
Fmoc-Thr(tBu)-Phe-OH

OEM Fmoc-Thr(tBu)-Phe-OH Company, Product

View Details
PT-141 10mg

OEM PT-141 10mg Suppliers, Exporter

View Details
NMN

OEM NMN Company, Companies

View Details
Rhodium(III) nitrate

OEM Rhodium(III) nitrate 10139-58-9 Supplier, Exporters

View Details
NAD+ 1000mg

OEM Nad+ 1000mg Company, Products

View Details